The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.

TitleThe eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.
Publication TypeJournal Article
Year of Publication2017
AuthorsRutherford SC, Stewart EN, Chen Z, Chadburn A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L
JournalLeuk Lymphoma
Pagination1-3
Date Published2017 Jun 02
ISSN1029-2403
DOI10.1080/10428194.2017.1323270
Alternate JournalLeuk. Lymphoma
PubMed ID28573908